PROLONG PHARMACEUTICALS, INC.
|PROLONG PHARMACEUTICALS, INC. Patent applications|
|Patent application number||Title||Published|
|20100184655||MODIFIED ERYTHROPOIETIN - This invention relates to novel protein conjugates, in particular, to novel pegylated proteins, and their methods of making and use. One aspect of the present invention relates to pegylated-erythropoietin having greater clinical efficacy and stability during shipment and storage than current erythropoietin formulations.||07-22-2010|